Table 4.
Pharmacology of individual bioactive compounds in inflammation
| Bioactive compound | Mechanism of action | Therapeutic effects | References |
|---|---|---|---|
| Amentoflavone | Inhibits pro-inflammatory cytokines and keratinocyte proliferation | Reduces skin thickness and inflammation | An et al. (2016) |
| Baicalin | Reduces inflammation and cytokine production | Alleviates psoriasis symptoms, reduces erythema and scaling | Hung et al. (2018) |
| Caffeic acid | Modulates inflammation and cytokine production | Reduces inflammatory response | Wen et al. (2020) |
| Chlorogenic acid | Modulates inflammation and cytokine production | Reduces inflammatory response | Wen et al. (2020) |
| Curcumin | Modulates cytokine production and inflammatory pathways | Improves PASI scores, reduces psoriatic symptoms | Zhang et al. (2022) |
| Delphinidin | Enhances caspase expression, promotes epidermal differentiation | Reduces psoriasis markers, inflammation, and promotes skin differentiation | Afaq et al. (2007) and Pal et al. (2015) |
| Epigallocatechin gallate | Exhibits anti-inflammatory and immunoregulatory properties | Reduces dermatitis severity and enhances antioxidant activity | Zhang et al. (2016) |
| Ferulic acid | Modulates inflammation and cytokine production | Reduces inflammatory response | Wen et al. (2020) |
| Genistein | Inhibits NF-κB and STAT3 signaling pathways | Reduces epidermal thickness and inflammatory factors | Wang et al. (2019) |
| Kaempferol | Reduces pro-inflammatory cytokines and increases regulatory T cells | Reduces skin lesions in psoriasis | Liu et al. (2019) |
| Quercetin | Reduces oxidative stress and modulates NF-κB pathway | Ameliorates psoriatic symptoms, improves histology | Chen et al. (2017a) |
| Resveratrol | Modulates inflammation and cytokine production | Reduces inflammatory response | Wen et al. (2020) |
| Taxifolin | Modulates Th cell differentiation and inhibits pro-inflammatory factors | Decreases inflammation in psoriasis model | Yuan et al. (2020) |
| Artesunate | Reduces γδ T cells and systemic inflammation | Decreases psoriasis scores, epidermal thickening, and Ki-67 expression | Huang et al. (2019) |
| Berberine | Inhibits CDK4/6-RB-CDC6 signaling axis and JAK-STAT3 activation | Reduces keratinocyte proliferation and IMQ-induced psoriasis lesions | Sun et al. (2019) |
| Khasianine | Inhibits NF-κB p65 activation and decreases IL-17A and IL-33 expression | Reduces inflammation and immune cell infiltration in psoriasis lesions | Yang et al. (2022) |
| Omega-3 fatty acids | Modulates inflammation and immune responses | Improves PASI and NAPSI scores, alleviates symptoms like scaling and pruritus | Balbás et al. (2011) and Clark et al. (2019) |
| Oxymatrine | Inhibits keratinocyte proliferation and regulates immune response | Reduces PASI score, maintains normal keratinocyte function | Chen et al. (2017b) |
| Paeoniflorin | Regulates Th17 response and cytokine secretion, affects STAT3 phosphorylation | Decreases keratinocyte overgrowth and immune cell infiltration | Zhao et al. (2016) |
| INM-A | Reduces IL-17A levels, alleviates inflammation and oxidative stress | Improves skin conditions in IMQ-induced mice | Lee et al. (2024) |